Will UnitedHealth Stock Recover?
Shares of embattled health insurance giant UnitedHealth (NYSE:UNH) plummeted by…
Buy
55
MDLZ Quote, Financials, Valuation and Earnings
Last price:
$61.87
Seasonality move
:
4.38%
Day range:
$59.88 - $61.73
52-week range:
$51.20 - $71.15
Dividend yield:
3.16%
P/E ratio:
32.53x
P/S ratio:
2.07x
P/B ratio:
3.05x
Volume:
8.6M
Avg. volume:
11.8M
1-year change:
1.69%
Market cap:
$78.8B
Revenue:
$38.5B
EPS (TTM):
$1.89
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $28.7B | $31.5B | $36B | $36.4B | $38.5B | |
| Revenue Growth (YoY) | 8.05% | 9.67% | 14.35% | 1.18% | 5.75% | |
| Cost of Revenues | $18.1B | $20.6B | $22.7B | $24.2B | $26.5B | |
| Gross Profit | $10.7B | $10.9B | $13.3B | $12.2B | $12B | |
| Gross Profit Margin | 37.1% | 34.63% | 37.02% | 33.59% | 31.17% | |
| R&D Expenses | $347M | $346M | $380M | $400M | $400M | |
| Selling, General & Admin | $6.3B | $7.4B | $8B | $7.4B | $7.2B | |
| Other Inc / (Exp) | -$178M | -$274M | $578M | -$224M | -- | |
| Operating Expenses | $6.1B | $7.1B | $7.7B | $6.9B | $7.1B | |
| Operating Income | $4.6B | $3.8B | $5.7B | $5.3B | $4.9B | |
| Net Interest Expenses | $365M | $428M | $550M | $508M | $599M | |
| EBT. Incl. Unusual Items | $5.1B | $3.2B | $6.3B | $5.9B | $3.2B | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $1.2B | $865M | $1.5B | $1.5B | $782M | |
| Net Income to Company | $4.3B | $2.7B | $5B | $4.6B | $2.5B | |
| Minority Interest in Earnings | $14M | $9M | $9M | $12M | $15M | |
| Net Income to Common Excl Extra Items | $4.3B | $2.7B | $5B | $4.6B | $2.5B | |
| Basic EPS (Cont. Ops) | $3.06 | $1.97 | $3.64 | $3.44 | $1.89 | |
| Diluted EPS (Cont. Ops) | $3.04 | $1.96 | $3.62 | $3.42 | $1.89 | |
| Weighted Average Basic Share | $1.4B | $1.4B | $1.4B | $1.3B | $1.3B | |
| Weighted Average Diluted Share | $1.4B | $1.4B | $1.4B | $1.3B | $1.3B | |
| EBITDA | $5.7B | $4.9B | $6.9B | $6.6B | $6.2B | |
| EBIT | $4.6B | $3.8B | $5.7B | $5.3B | $4.9B | |
| Revenue (Reported) | $28.7B | $31.5B | $36B | $36.4B | $38.5B | |
| Operating Income (Reported) | $4.6B | $3.8B | $5.7B | $5.3B | $4.9B | |
| Operating Income (Adjusted) | $4.6B | $3.8B | $5.7B | $5.3B | $4.9B | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $7.7B | $8.7B | $9.3B | $9.6B | $10.5B | |
| Revenue Growth (YoY) | 4.93% | 13.54% | 7.12% | 3.11% | 9.29% | |
| Cost of Revenues | $4.9B | $5.7B | $5.9B | $6.8B | $7.3B | |
| Gross Profit | $2.7B | $3B | $3.4B | $2.8B | $3.2B | |
| Gross Profit Margin | 35.77% | 34.84% | 36.23% | 28.75% | 30.35% | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $1.7B | $2.1B | $2.3B | $2B | $1.9B | |
| Other Inc / (Exp) | $47M | -$136M | -$134M | -$297M | -- | |
| Operating Expenses | $1.6B | $2.3B | $2.1B | $1.8B | $1.9B | |
| Operating Income | $1.1B | $776M | $1.2B | $960M | $1.3B | |
| Net Interest Expenses | $90M | $134M | $118M | $127M | $154M | |
| EBT. Incl. Unusual Items | $1.1B | $772M | $1.2B | $1.9B | $919M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $238M | $270M | $257M | $216M | $261M | |
| Net Income to Company | $1B | $584M | $950M | $1.7B | $669M | |
| Minority Interest in Earnings | $2M | $1M | -- | $3M | $4M | |
| Net Income to Common Excl Extra Items | $1B | $584M | $950M | $1.7B | $669M | |
| Basic EPS (Cont. Ops) | $0.72 | $0.43 | $0.70 | $1.31 | $0.52 | |
| Diluted EPS (Cont. Ops) | $0.71 | $0.42 | $0.70 | $1.30 | $0.51 | |
| Weighted Average Basic Share | $1.4B | $1.4B | $1.4B | $1.3B | $1.3B | |
| Weighted Average Diluted Share | $1.4B | $1.4B | $1.4B | $1.3B | $1.3B | |
| EBITDA | $1.4B | $1.1B | $1.6B | $1.3B | $1.6B | |
| EBIT | $1.1B | $776M | $1.2B | $960M | $1.3B | |
| Revenue (Reported) | $7.7B | $8.7B | $9.3B | $9.6B | $10.5B | |
| Operating Income (Reported) | $1.1B | $776M | $1.2B | $960M | $1.3B | |
| Operating Income (Adjusted) | $1.1B | $776M | $1.2B | $960M | $1.3B | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $28.7B | $31.5B | $36B | $36.4B | $38.5B | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $18.1B | $20.6B | $22.7B | $22.4B | $26.6B | |
| Gross Profit | $10.7B | $10.9B | $13.3B | $14.1B | $11.9B | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $6.3B | $7.4B | $8B | $7.4B | $7.2B | |
| Other Inc / (Exp) | -$178M | -$274M | $578M | -$224M | -- | |
| Operating Expenses | $6.1B | $7B | $7.8B | $7.2B | $7.1B | |
| Operating Income | $4.6B | $3.9B | $5.6B | $6.9B | $4.8B | |
| Net Interest Expenses | $365M | $428M | $550M | $508M | $599M | |
| EBT. Incl. Unusual Items | $5.1B | $3.2B | $6.3B | $5.9B | $3.2B | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $1.2B | $865M | $1.5B | $1.5B | $782M | |
| Net Income to Company | $4.3B | $2.7B | $5B | $4.6B | $2.5B | |
| Minority Interest in Earnings | $14M | $9M | $9M | $12M | $15M | |
| Net Income to Common Excl Extra Items | $4.3B | $2.7B | $5B | $4.6B | $2.5B | |
| Basic EPS (Cont. Ops) | $3.06 | $1.97 | $3.64 | $3.44 | $1.89 | |
| Diluted EPS (Cont. Ops) | $3.04 | $1.96 | $3.62 | $3.42 | $1.89 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | $5.7B | $5B | $6.8B | $8.2B | $6.1B | |
| EBIT | $4.6B | $3.9B | $5.6B | $6.9B | $4.8B | |
| Revenue (Reported) | $28.7B | $31.5B | $36B | $36.4B | $38.5B | |
| Operating Income (Reported) | $4.6B | $3.9B | $5.6B | $6.9B | $4.8B | |
| Operating Income (Adjusted) | $4.6B | $3.9B | $5.6B | $6.9B | $4.8B | |
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | 2026-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $31.5B | $36B | $36.4B | $38.5B | -- | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $20.6B | $22.7B | $22.4B | $26.6B | -- | |
| Gross Profit | $10.9B | $13.3B | $14.1B | $11.9B | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $7.4B | $8B | $7.4B | $7.2B | -- | |
| Other Inc / (Exp) | -$274M | $578M | -$224M | -$266M | -- | |
| Operating Expenses | $7B | $7.8B | $7.2B | $7.1B | -- | |
| Operating Income | $3.9B | $5.6B | $6.9B | $4.8B | -- | |
| Net Interest Expenses | $428M | $550M | $508M | $599M | -- | |
| EBT. Incl. Unusual Items | $3.2B | $6.3B | $5.9B | $3.2B | -- | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $865M | $1.5B | $1.5B | $782M | -- | |
| Net Income to Company | $2.7B | $5B | $4.6B | $2.5B | -- | |
| Minority Interest in Earnings | $9M | $9M | $12M | $15M | -- | |
| Net Income to Common Excl Extra Items | $2.7B | $5B | $4.6B | $2.5B | -- | |
| Basic EPS (Cont. Ops) | $1.97 | $3.64 | $3.44 | $1.89 | -- | |
| Diluted EPS (Cont. Ops) | $1.96 | $3.62 | $3.42 | $1.89 | -- | |
| Weighted Average Basic Share | $5.5B | $5.5B | $5.4B | $5.2B | -- | |
| Weighted Average Diluted Share | $5.5B | $5.5B | $5.4B | $5.2B | -- | |
| EBITDA | $5B | $6.8B | $8.2B | $6.1B | -- | |
| EBIT | $3.9B | $5.6B | $6.9B | $4.8B | -- | |
| Revenue (Reported) | $31.5B | $36B | $36.4B | $38.5B | -- | |
| Operating Income (Reported) | $3.9B | $5.6B | $6.9B | $4.8B | -- | |
| Operating Income (Adjusted) | $3.9B | $5.6B | $6.9B | $4.8B | -- | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $3.6B | $1.9B | $1.9B | $1.4B | $2.2B | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | $2.3B | $3.1B | $3.6B | $3.9B | $3.9B | |
| Inventory | $2.7B | $3.4B | $3.6B | $3.8B | $4.4B | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | $900M | $880M | $1.8B | $3.3B | -- | |
| Total Current Assets | $10.3B | $10.1B | $11.7B | $13.2B | $13B | |
| Property Plant And Equipment | $9.3B | $9.7B | $10.4B | $10.2B | $11.4B | |
| Long-Term Investments | $5.3B | $4.9B | $3.5B | $989M | $829M | |
| Goodwill | $22B | $23.5B | $23.9B | $23B | -- | |
| Other Intangibles | $18.3B | $19.7B | $19.8B | $18.8B | -- | |
| Other Long-Term Assets | $371M | $1.9B | $886M | $1.2B | -- | |
| Total Assets | $67.1B | $71.2B | $71.4B | $68.5B | $71.5B | |
| Accounts Payable | $6.7B | $7.6B | $8.3B | $9.4B | $10.1B | |
| Accrued Expenses | $2.1B | $2.4B | $2.7B | $2.6B | -- | |
| Current Portion Of Long-Term Debt | $1.7B | $383M | $2.1B | $2B | -- | |
| Current Portion Of Capital Lease Obligations | $82M | -- | -- | -- | -- | |
| Other Current Liabilities | $2.4B | $3.2B | $4.3B | $4.5B | -- | |
| Total Current Liabilities | $14B | $16.7B | $19B | $19.5B | $21.9B | |
| Long-Term Debt | $18B | $20.8B | $17.4B | $16.3B | $17.8B | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $38.8B | $44.2B | $43B | $41.5B | $45.6B | |
| Common Stock | -- | -- | -- | -- | -- | |
| Other Common Equity Adj | -$10.6B | -$10.9B | -$10.9B | -$12.5B | -- | |
| Common Equity | $28.3B | $26.9B | $28.3B | $26.9B | $25.8B | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | $54M | $37M | $34M | $26M | $53M | |
| Total Equity | $28.3B | $26.9B | $28.4B | $27B | $25.9B | |
| Total Liabilities and Equity | $67.1B | $71.2B | $71.4B | $68.5B | $71.5B | |
| Cash and Short Terms | $3.6B | $1.9B | $1.9B | $1.4B | $2.2B | |
| Total Debt | $19.8B | $21.1B | $19.5B | $18.3B | $19.1B | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $3.6B | $1.9B | $1.9B | $1.4B | $2.2B | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | $2.3B | $3.1B | $3.6B | $3.9B | $3.9B | |
| Inventory | $2.7B | $3.4B | $3.6B | $3.8B | $4.4B | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | $900M | $880M | $1.8B | $3.3B | -- | |
| Total Current Assets | $10.3B | $10.1B | $11.7B | $13.2B | $13B | |
| Property Plant And Equipment | $9.3B | $9.7B | $10.4B | $10.2B | $11.4B | |
| Long-Term Investments | $5.3B | $4.9B | $3.5B | $989M | $829M | |
| Goodwill | $22B | $23.5B | $23.9B | $23B | -- | |
| Other Intangibles | $18.3B | $19.7B | $19.8B | $18.8B | -- | |
| Other Long-Term Assets | $371M | $1.9B | $886M | $1.2B | -- | |
| Total Assets | $67.1B | $71.2B | $71.4B | $68.5B | $71.5B | |
| Accounts Payable | $6.7B | $7.6B | $8.3B | $9.4B | $10.1B | |
| Accrued Expenses | $2.1B | $2.4B | $2.7B | $2.6B | -- | |
| Current Portion Of Long-Term Debt | $1.7B | $383M | $2.1B | $2B | -- | |
| Current Portion Of Capital Lease Obligations | $82M | -- | -- | -- | -- | |
| Other Current Liabilities | $2.4B | $3.2B | $4.3B | $4.5B | -- | |
| Total Current Liabilities | $14B | $16.7B | $19B | $19.5B | $21.9B | |
| Long-Term Debt | $18B | $20.8B | $17.4B | $16.3B | $17.8B | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $38.8B | $44.2B | $43B | $41.5B | $45.6B | |
| Common Stock | -- | -- | -- | -- | -- | |
| Other Common Equity Adj | -$10.6B | -$10.9B | -$10.9B | -$12.5B | -- | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | $54M | $37M | $34M | $26M | $53M | |
| Total Equity | $28.3B | $26.9B | $28.4B | $27B | $25.9B | |
| Total Liabilities and Equity | $67.1B | $71.2B | $71.4B | $68.5B | $71.5B | |
| Cash and Short Terms | $3.6B | $1.9B | $1.9B | $1.4B | $2.2B | |
| Total Debt | $19.8B | $21.1B | $19.5B | $18.3B | $19.1B | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $4.3B | $2.7B | $5B | $4.6B | $2.5B | |
| Depreciation & Amoritzation | $1.1B | $1.1B | $1.2B | $1.3B | $1.4B | |
| Stock-Based Compensation | $121M | $120M | $146M | $147M | $114M | |
| Change in Accounts Receivable | -$197M | -$719M | -$628M | -$519M | $433M | |
| Change in Inventories | -$170M | -$635M | -$193M | -$458M | -$253M | |
| Cash From Operations | $4.1B | $3.9B | $4.7B | $4.9B | $4.5B | |
| Capital Expenditures | $965M | $906M | $1.1B | $1.4B | $1.3B | |
| Cash Acquisitions | $833M | $5.3B | -$19M | $240M | $15M | |
| Cash From Investing | -$26M | -$4.9B | $2.8B | $526M | -$1.2B | |
| Dividends Paid (Ex Special Dividend) | $1.8B | $2B | $2.2B | $2.3B | $2.5B | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $6.1B | $6.4B | $344M | $1.7B | -- | |
| Long-Term Debt Repaid | -$6.2B | -$3B | -$4.4B | -$2.9B | -- | |
| Repurchase of Common Stock | $2.1B | $2B | $1.5B | $2.3B | $2.4B | |
| Other Financing Activities | -$1M | $174M | $173M | $129M | -- | |
| Cash From Financing | -$4.1B | -$456M | -$7.6B | -$5.8B | -$2.8B | |
| Beginning Cash (CF) | $3.6B | $1.9B | $1.9B | $1.4B | $2.2B | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -$97M | -$1.6B | -$64M | -$484M | $795M | |
| Ending Cash (CF) | $3.3B | $174M | $1.8B | $776M | $3.2B | |
| Levered Free Cash Flow | $3.2B | $3B | $3.6B | $3.5B | $3.2B | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $1B | $584M | $950M | $1.7B | $669M | |
| Depreciation & Amoritzation | $276M | $288M | $313M | $331M | $352M | |
| Stock-Based Compensation | $33M | $32M | $37M | $35M | $30M | |
| Change in Accounts Receivable | $220M | -$94M | $59M | -$249M | $525M | |
| Change in Inventories | $172M | $110M | $291M | $252M | $714M | |
| Cash From Operations | $1.4B | $1.4B | $1.6B | $1.5B | $2.4B | |
| Capital Expenditures | $326M | $285M | $332M | $405M | $398M | |
| Cash Acquisitions | -- | $1.3B | -- | $240M | -- | |
| Cash From Investing | -$132M | -$1.5B | $1B | $1.7B | -$266M | |
| Dividends Paid (Ex Special Dividend) | $489M | $528M | $579M | $627M | $645M | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | $194M | $544M | $88M | -$1.1B | -- | |
| Long-Term Debt Repaid | -$349M | -$27M | -$1.1B | -$380M | -- | |
| Repurchase of Common Stock | $286M | $179M | $888M | $1.1B | $492M | |
| Other Financing Activities | $39M | $31M | $39M | -$3M | -- | |
| Cash From Financing | -$1.1B | -$159M | -$2.5B | -$3.2B | -$1.4B | |
| Beginning Cash (CF) | $3.6B | $1.9B | $1.9B | $1.4B | $2.2B | |
| Foreign Exchange Rate Adjustment | -$46M | -$2M | $101M | -$106M | $11M | |
| Additions / Reductions | $145M | -$247M | $207M | -$173M | $729M | |
| Ending Cash (CF) | $3.7B | $1.7B | $2.2B | $1.1B | $2.9B | |
| Levered Free Cash Flow | $1.1B | $1.1B | $1.2B | $1.1B | $2B | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $4.3B | $2.7B | $5B | $4.6B | $2.5B | |
| Depreciation & Amoritzation | $1.1B | $1.1B | $1.2B | $1.3B | $1.4B | |
| Stock-Based Compensation | $121M | $120M | $146M | $147M | $114M | |
| Change in Accounts Receivable | -$197M | -$719M | -$628M | -$519M | $433M | |
| Change in Inventories | -$170M | -$635M | -$193M | -$458M | -$253M | |
| Cash From Operations | $4.1B | $3.9B | $4.7B | $4.9B | $4.5B | |
| Capital Expenditures | $965M | $906M | $1.1B | $1.4B | $1.3B | |
| Cash Acquisitions | $833M | $5.3B | -$19M | $240M | $15M | |
| Cash From Investing | -$26M | -$4.9B | $2.8B | $526M | -$1.2B | |
| Dividends Paid (Ex Special Dividend) | $1.8B | $2B | $2.2B | $2.3B | $2.5B | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $6.1B | $6.4B | $344M | $1.7B | -- | |
| Long-Term Debt Repaid | -$6.2B | -$3B | -$4.4B | -$2.9B | -- | |
| Repurchase of Common Stock | $2.1B | $2B | $1.5B | $2.3B | $2.4B | |
| Other Financing Activities | -$1M | $174M | $173M | $129M | -- | |
| Cash From Financing | -$4.1B | -$456M | -$7.6B | -$5.8B | -$2.8B | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -$97M | -$1.6B | -$64M | -$484M | $795M | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | $3.2B | $3B | $3.6B | $3.5B | $3.2B | |
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | 2026-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $2.7B | $5B | $4.6B | $2.5B | -- | |
| Depreciation & Amoritzation | $1.1B | $1.2B | $1.3B | $1.4B | -- | |
| Stock-Based Compensation | $120M | $146M | $147M | $114M | -- | |
| Change in Accounts Receivable | -$719M | -$628M | -$519M | $433M | -- | |
| Change in Inventories | -$635M | -$193M | -$458M | -$253M | -- | |
| Cash From Operations | $3.9B | $4.7B | $4.9B | $4.5B | -- | |
| Capital Expenditures | $906M | $1.1B | $1.4B | $1.3B | -- | |
| Cash Acquisitions | $5.3B | -$19M | $240M | $15M | -- | |
| Cash From Investing | -$4.9B | $2.8B | $526M | -$1.2B | -- | |
| Dividends Paid (Ex Special Dividend) | $2B | $2.2B | $2.3B | $2.5B | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | $6.4B | $344M | $1.7B | $3.2B | -- | |
| Long-Term Debt Repaid | -$3B | -$4.4B | -$2.9B | -$1.2B | -- | |
| Repurchase of Common Stock | $2B | $1.5B | $2.3B | $2.4B | -- | |
| Other Financing Activities | $174M | $173M | $129M | $83M | -- | |
| Cash From Financing | -$456M | -$7.6B | -$5.8B | -$2.8B | -- | |
| Beginning Cash (CF) | $8B | $7.1B | $5.9B | $6.9B | -- | |
| Foreign Exchange Rate Adjustment | -$169M | -$32M | -$140M | $236M | -- | |
| Additions / Reductions | -$1.6B | -$64M | -$484M | $795M | -- | |
| Ending Cash (CF) | $6.3B | $7B | $5.3B | $7.9B | -- | |
| Levered Free Cash Flow | $3B | $3.6B | $3.5B | $3.2B | -- | |
Related Companies
Get MDLZ Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
MDLZ
Sector
P/E ratio
32.53x
17.78x
PEG ratio
2.30x
0.12x
P/B ratio
3.05x
1.51x
Price / LTM sales
2.07x
0.52x
Growth Metrics
MDLZ
Sector
Revenue growth
9.29%
2.79%
Earnings growth
-60.48%
2.09%
Revenue (5-year growth)
7.71%
3.32%
Earnings forecast
$0.70
$0.26
Profitability
MDLZ
Sector
Profitability FY 2025
$12B
$254M
Return on invested capital
5.24%
4.24%
Return on assets
3.51%
3.02%
Return on equity
9.4%
7.5%
Earnings Date
Last Earnings Date
Feb
3
Next Earnings Date
Apr
28
Estimated Next Earnings Date
May
5
Balance Sheet
MDLZ
Sector
Total cash
$2.2B
$85.2M
Short term investments
--
$31.1M
Total assets
$71.5B
$1B
Long term debt
$19.1B
$5.9M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Lumentum The Best Laser Stock to Buy?
Though certainly less well-known than the huge tech businesses that…
Is Planet Fitness Stock Undervalued?
Planet Fitness (NYSE:PLNT) has had a difficult 12 months, retreating…
Stock Ideas
Buy
56
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 65x
Buy
58
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 37x
Sell
40
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 29x
Alerts
Buy
91
TDC alert for Feb 12
Teradata Corp. [TDC] is down 11.64% over the past day.
Buy
67
DIOD alert for Feb 12
Diodes, Inc. [DIOD] is down 7.63% over the past day.
Buy
77
VRT alert for Feb 12
Vertiv Holdings Co. [VRT] is down 4.79% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
